These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 30325775)
21. Expanding HIV-1 subtype B transmission networks among men who have sex with men in Poland. Parczewski M; Leszczyszyn-Pynka M; Witak-Jędra M; Szetela B; Gąsiorowski J; Knysz B; Bociąga-Jasik M; Skwara P; Grzeszczuk A; Jankowska M; Barałkiewicz G; Mozer-Lisewska I; Łojewski W; Kozieł K; Grąbczewska E; Jabłonowska E; Urbańska A PLoS One; 2017; 12(2):e0172473. PubMed ID: 28234955 [TBL] [Abstract][Full Text] [Related]
22. Large cluster outbreaks sustain the HIV epidemic among MSM in Quebec. Brenner BG; Ibanescu RI; Hardy I; Stephens D; Otis J; Moodie E; Grossman Z; Vandamme AM; Roger M; Wainberg MA; AIDS; 2017 Mar; 31(5):707-717. PubMed ID: 28005684 [TBL] [Abstract][Full Text] [Related]
23. Patterns of transmitted HIV drug resistance in Europe vary by risk group. Frentz D; van de Vijver D; Abecasis A; Albert J; Hamouda O; Jørgensen L; Kücherer C; Struck D; Schmit JC; Vercauteren J; Asjö B; Balotta C; Bergin C; Beshkov D; Camacho R; Clotet B; Griskevicius A; Grossman Z; Horban A; Kolupajeva T; Korn K; Kostrikis L; Linka KL; Nielsen C; Otelea D; Paraskevis D; Paredes R; Poljak M; Puchhammer-Stöckl E; Sönnerborg A; Stanekova D; Stanojevic M; Vandamme AM; Boucher C; Wensing A; PLoS One; 2014; 9(4):e94495. PubMed ID: 24721998 [TBL] [Abstract][Full Text] [Related]
24. Clinical, virological and phylogenetic characterization of a multiresistant HIV-1 strain outbreak in naive patients in southern Spain. Viciana I; González-Domenech CM; Palacios R; Delgado M; Del Arco A; Tellez F; Jarilla F; Fernández S; Clavijo E; Santos J J Antimicrob Chemother; 2016 Feb; 71(2):357-61. PubMed ID: 26483513 [TBL] [Abstract][Full Text] [Related]
25. Emergence of an HIV-1 cluster harbouring the major protease L90M mutation among treatment-naïve patients in Tel Aviv, Israel. Turner D; Amit S; Chalom S; Penn O; Pupko T; Katchman E; Matus N; Tellio H; Katzir M; Avidor B HIV Med; 2012 Apr; 13(4):202-6. PubMed ID: 22093289 [TBL] [Abstract][Full Text] [Related]
26. Increasing proportions of HIV-1 non-B subtypes and of NNRTI resistance between 2013 and 2016 in Germany: Results from the national molecular surveillance of new HIV-diagnoses. Hauser A; Hofmann A; Meixenberger K; Altmann B; Hanke K; Bremer V; Bartmeyer B; Bannert N PLoS One; 2018; 13(11):e0206234. PubMed ID: 30408827 [TBL] [Abstract][Full Text] [Related]
27. Increasing Frequency and Transmission of HIV-1 Non-B Subtypes Among Men Who Have Sex With Men in the Swiss HIV Cohort Study. Duran Ramirez JJ; Ballouz T; Nguyen H; Kusejko K; Chaudron SE; Huber M; Hirsch HH; Perreau M; Ramette A; Yerly S; Cavassini M; Stöckle M; Furrer H; Vernazza P; Bernasconi E; Günthard HF; Kouyos RD; J Infect Dis; 2022 Jan; 225(2):306-316. PubMed ID: 34260728 [TBL] [Abstract][Full Text] [Related]
28. HIV-1 Circulating Recombinant Forms (CRFs) and Unique Recombinant Forms (URFs) in Israel, 2010-2018. Wagner T; Zuckerman NS; Wax M; Shirazi R; Gozlan Y; Girshengorn S; Marom R; Mendelson E; Turner D; Mor O Viruses; 2022 Sep; 14(9):. PubMed ID: 36146776 [TBL] [Abstract][Full Text] [Related]
29. A phylotype-based analysis highlights the role of drug-naive HIV-positive individuals in the transmission of antiretroviral resistance in the UK. Mourad R; Chevennet F; Dunn DT; Fearnhill E; Delpech V; Asboe D; Gascuel O; Hue S; AIDS; 2015 Sep; 29(15):1917-25. PubMed ID: 26355570 [TBL] [Abstract][Full Text] [Related]
30. HIV-1 transmitted drug resistance in Slovenia and its impact on predicted treatment effectiveness: 2011-2016 update. Lunar MM; Židovec Lepej S; Tomažič J; Vovko TD; Pečavar B; Turel G; Maver M; Poljak M PLoS One; 2018; 13(4):e0196670. PubMed ID: 29698470 [TBL] [Abstract][Full Text] [Related]
31. Transmitted HIV drug resistance in antiretroviral-treatment-naive patients from Poland differs by transmission category and subtype. Parczewski M; Leszczyszyn-Pynka M; Witak-Jędra M; Maciejewska K; Rymer W; Szymczak A; Szetela B; Gąsiorowski J; Bociąga-Jasik M; Skwara P; Garlicki A; Grzeszczuk A; Rogalska M; Jankowska M; Lemańska M; Hlebowicz M; Barałkiewicz G; Mozer-Lisewska I; Mazurek R; Lojewski W; Grąbczewska E; Olczak A; Jabłonowska E; Clark J; Urbańska A J Antimicrob Chemother; 2015 Jan; 70(1):233-42. PubMed ID: 25248322 [TBL] [Abstract][Full Text] [Related]
32. HIV Type 1 transmission networks among men having sex with men and heterosexuals in Kenya. Bezemer D; Faria NR; Hassan A; Hamers RL; Mutua G; Anzala O; Mandaliya K; Cane P; Berkley JA; Rinke de Wit TF; Wallis C; Graham SM; Price MA; Coutinho RA; Sanders EJ AIDS Res Hum Retroviruses; 2014 Feb; 30(2):118-26. PubMed ID: 23947948 [TBL] [Abstract][Full Text] [Related]
33. Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe. Frentz D; Van de Vijver DA; Abecasis AB; Albert J; Hamouda O; Jørgensen LB; Kücherer C; Struck D; Schmit JC; Vercauteren J; Åsjö B; Balotta C; Beshkov D; Camacho RJ; Clotet B; Coughlan S; Griskevicius A; Grossman Z; Horban A; Kolupajeva T; Korn K; Kostrikis LG; Liitsola K; Linka M; Nielsen C; Otelea D; Paraskevis D; Paredes R; Poljak M; Puchhammer-Stöckl E; Sönnerborg A; Stanekova D; Stanojevic M; Van Wijngaerden E; Wensing AM; Boucher CA; BMC Infect Dis; 2014 Jul; 14():407. PubMed ID: 25047543 [TBL] [Abstract][Full Text] [Related]
34. Short communication: prevalence of HIV type 1 transmitted drug resistance in Slovenia: 2005-2010. Lunar MM; Židovec Lepej S; Abecasis AB; Tomažič J; Vidmar L; Karner P; Vovko TD; Pečavar B; Maver PJ; Seme K; Poljak M AIDS Res Hum Retroviruses; 2013 Feb; 29(2):343-9. PubMed ID: 22860694 [TBL] [Abstract][Full Text] [Related]
35. Molecular Epidemiology of the HIV-1 Subtype B Sub-Epidemic in Bulgaria. Alexiev I; M Campbell E; Knyazev S; Pan Y; Grigorova L; Dimitrova R; Partsuneva A; Gancheva A; Kostadinova A; Seguin-Devaux C; M Switzer W Viruses; 2020 Apr; 12(4):. PubMed ID: 32295123 [TBL] [Abstract][Full Text] [Related]
36. Appearance of drug resistance-associated mutations in human immunodeficiency virus type 1 protease and reverse transcriptase derived from drug-treated Indonesian patients. Khairunisa SQ; Kotaki T; Witaningrum AM; Yunifiar M MQ; Sukartiningrum SD; Nasronudin ; Kameoka M AIDS Res Hum Retroviruses; 2015 Feb; 31(2):255-9. PubMed ID: 25348045 [TBL] [Abstract][Full Text] [Related]
38. Primary HIV-1 drug resistance in the C-terminal domains of viral reverse transcriptase among drug-naïve patients from Southern Brazil. Santos AF; Silveira J; Muniz CP; Tornatore M; Góes LR; Mendoza-Sassi RA; Martinez AM; Tupinambás U; Greco DB; Soares MA J Clin Virol; 2011 Dec; 52(4):373-6. PubMed ID: 21975076 [TBL] [Abstract][Full Text] [Related]
39. Transmitted HIV type 1 drug resistance in newly diagnosed Cuban patients. Machado LY; Dubed M; Díaz H; Ruiz N; Romay D; Váldes N; Blanco M; Silva E AIDS Res Hum Retroviruses; 2013 Feb; 29(2):411-4. PubMed ID: 22985307 [TBL] [Abstract][Full Text] [Related]
40. Analysis of the diversity of the HIV-1 pol gene and drug resistance associated changes among drug-naïve patients in Burkina Faso. Tebit DM; Sangaré L; Tiba F; Saydou Y; Makamtse A; Somlare H; Bado G; Kouldiaty BG; Zabsonre I; Yameogo SL; Sathiandee K; Drabo JY; Kräusslich HG J Med Virol; 2009 Oct; 81(10):1691-701. PubMed ID: 19697403 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]